Treatment of chronic obstructive pulmonary disease (copd) by...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/415 (2006.01)

Patent

CA 2081768

2081768 9116891 PCTABS00008 A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of chronic obstructive pulmonary disease (copd) by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of chronic obstructive pulmonary disease (copd) by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic obstructive pulmonary disease (copd) by... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2056262

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.